Zelira Therapeutics Ltd (ASX: ZLD) Share Price and News
52 Week Range
1 Year Return
() Chart and Price Data
Zelira Therapeutics Ltd (ASX: ZLD) Latest News
James Mickleboro | April 23, 2018 1:31pm
James Mickleboro | April 23, 2018 11:37am
Tom Richardson | March 8, 2018 4:53pm
James Mickleboro | February 15, 2018 7:47am
About Zelira Therapeutics Ltd (ASX: ZLD)
Zelira Therapeutics Ltd (ASX: ZLD) is a leading global therapeutic medicinal cannabis company with access to the world’s fastest growing cannabis markets. Formerly Zelda Therapeutics, Zelira owns a portfolio of proprietary products and a pipeline of candidates undergoing clinical development.
The company focus is on developing branded cannabis products for the treatment of a variety of medical conditions, including insomnia, autism and opioid reduction. Zelira has launched two proprietary formulations under the HOPE brand for autism in multiple US-states with plans to expand into global markets in 2020.
Director TransactionsData provided by Morningstar.
Directors & ManagementData provided by Morningstar.
Top Share HoldersData provided by Morningstar.
|Sunset Capital Management Pty Ltd||55,413,617||4.85%|
|Gemelli Nominees Pty Ltd||49,587,680||4.34%|
|Mal Washer Nominees Pty Ltd||35,198,688||3.08%|
|Capricorn Investment Partners (Nominees) Pty Ltd||17,577,883||1.54%|
|Citicorp Nominees Pty Limited||16,756,434||1.47%|
|HSBC Custody Nominees (Australia) Limited||16,699,968||1.46%|
|Mr Torsten M Geers||16,413,065||1.44%|
|Mr Zoltan Kerekes||16,413,065||1.44%|
|Ms Lisa Gray||16,413,065||1.44%|
|Sharri J Rochlin||16,413,065||1.44%|
|Ubs Nominees Pty Ltd||15,800,000||1.38%|
|JP Morgan Nominees Australia Pty Limited||13,930,688||1.22%|
|Mera I LLC \C||13,879,566||1.22%|
|Mr Amit Gupta||11,529,999||1.01%|
|Celtic Capital Pty Ltd||11,200,000||0.98%|
|Copper Lake Holdings Limited||10,075,203||0.88%|
|Mr Alan Trounson||10,075,203||0.88%|
|Xena Advisors Llc||8,888,889||0.78%|